Ferenci, P; Bergholz, U; Laferl, H; Gurguta, C; Maieron, A; Gschwantler, M; Brunner, H; Hubmann, R; Datz, C; Bischof, M; Stauber, R; Steindl-Munda, P.
Is shorter treatment with peginterferon alfa-2a (40KD) (PEGASYS (R)) plus ribavirin (COPEGUS (R)) possible in HCV genotype 1 'super-responders'? preliminary results of a prospective randomized clinical trial
HEPATOLOGY 2005 42: -.
Web of Science